Pinealon (EDR)
Synthetic Tripeptide · Neuroprotection & Cognitive Enhancement
Overview
Developed in Russia, Pinealon demonstrates unique DNA-interaction for neuroprotection and cognitive enhancement. Benefits traumatic brain injury recovery and age-related cognitive decline with excellent safety profile.
Penetrates nuclear membranes to directly interact with DNA, modulates gene expression via histone H1.3 binding and MAPK/ERK pathway activation.
Clinical protocol of 5mg daily showed significant cognitive improvements in 72-patient study.
Subcutaneous administration allows systemic circulation to brain tissue for neuroprotective effects.
Caspase-3 suppression, ROS reduction, and excitotoxicity protection.
Enhanced neurotransmitter function with 1.9x serotonin increase in cell cultures.
Mechanism
Developed in Russia, Pinealon demonstrates unique DNA-interaction for neuroprotection and cognitive enhancement. Benefits traumatic brain injury recovery and age-related cognitive decline with excellent safety profile.
Penetrates nuclear membranes to directly interact with DNA, modulates gene expression via histone H1.3 binding and MAPK/ERK pathway activation.
Clinical protocol of 5mg daily showed significant cognitive improvements in 72-patient study.
Research areas
- Developed in Russia, Pinealon demonstrates unique DNA-interaction for neuroprotection and cognitive enhancement. Benefits traumatic brain injury recovery and age-related cognitive decline with excellent safety profile.
- Penetrates nuclear membranes to directly interact with DNA, modulates gene expression via histone H1.3 binding and MAPK/ERK pathway activation.
- Clinical protocol of 5mg daily showed significant cognitive improvements in 72-patient study.
- Subcutaneous administration allows systemic circulation to brain tissue for neuroprotective effects.
- Caspase-3 suppression, ROS reduction, and excitotoxicity protection.
- Enhanced neurotransmitter function with 1.9x serotonin increase in cell cultures.
- 100 ng/kg optimal dose improved spatial learning in hippocampus.
- Irisin expression increases linked to telomere protection and mitochondrial enhancement.
- 32-patient study showed significant improvements in aging indicators over 20-30 days.
Research notes
- Minimal injection site reactions
- Mild gastrointestinal adjustment
- Occasional headache
- Severe headaches or mood changes
- Persistent injection site reactions
- Signs of infection at injection site
- Unusual neurological symptoms
- Allergic reactions
- Pregnancy
- Lactation
FAQs
Does Pinealon really interact directly with DNA, or is that marketing?
It's verified science, not marketing. Pinealon penetrates nuclear membranes and directly binds to histone H1.3 and DNA structures to modulate gene expression. Multiple peer-reviewed studies document this mechanism. It's one of the few peptides that works through direct DNA interaction rather than receptor binding.
Can I take Pinealon orally, or does it need injection?
Both work. Oral forms (0.2mg twice daily) use the 3-amino acid structure that survives stomach acid. Injection (5mg daily SubQ) offers higher bioavailability. Oral is more convenient, but injection provides direct systemic delivery. Choose based on convenience vs. guaranteed absorption preference.
Why is 40+ years of Russian clinical use relevant if it's not FDA-approved?
Russian clinical use demonstrates long-term safety data in thousands of patients—much more than most research peptides have. While it doesn't equal FDA approval, 40 years of safety documentation in clinical settings is meaningful evidence of tolerability. However, rigorous Western clinical trials remain absent.
How does Pinealon compare to P21 for brain protection?
Both target neuroprotection but work differently. Pinealon modulates MAPK/ERK pathways and increases serotonin (more mood support), while P21 increases BDNF and promotes neurogenesis (more cognitive/learning focus). Pinealon has clinical evidence; P21 is preclinical. Pinealon is better-established for TBI recovery.